Biomarkers of Physical Frailty and Sarcopenia: Coming up to the Place?

Research output: Contribution to journalReview articlepeer-review


Physical frailty and sarcopenia (PF&S) recapitulates all the hallmarks of aging and has become a focus in geroscience. Factors spanning muscle-specific processes (e.g., mitochondrial dysfunction in skeletal myocytes) to systemic changes (e.g., inflammation and amino acid dysmetabolism) have been pinpointed as possible contributors to PF&S pathophysiology. However, the search for PF&S biomarkers allowing the early identification and tracking of the condition over time is ongoing. This is mainly due to the phenotypic heterogeneity of PF&S, its unclear pathophysiology, and the frequent superimposition of other age-related conditions. Hence, presently, the identification of PF&S relies upon clinical, functional, and imaging parameters. The adoption of multi-marker approaches (combined with multivariate modeling) has shown great potential for addressing the complexity of PF&S pathophysiology and identifying candidate biological markers. Well-designed longitudinal studies are necessary for the incorporation of reliable biomarkers into clinical practice and for unveiling novel targets that are amenable to interventions.

Original languageEnglish
Article number5635
JournalInternational Journal of Molecular Sciences
Issue number16
Publication statusPublished - Aug 6 2020


  • cytokines
  • exosomes
  • extracellular vesicles
  • geroscience
  • gut dysbiosis
  • inflammation
  • metabolomics
  • mitochondrial dysfunction
  • physical performance
  • skeletal muscle

ASJC Scopus subject areas

  • Catalysis
  • Molecular Biology
  • Spectroscopy
  • Computer Science Applications
  • Physical and Theoretical Chemistry
  • Organic Chemistry
  • Inorganic Chemistry


Dive into the research topics of 'Biomarkers of Physical Frailty and Sarcopenia: Coming up to the Place?'. Together they form a unique fingerprint.

Cite this